Area of research
Rheumatology · Hematology
Research interest
Research interests include Tofacitinib, Medicine, Rheumatoid arthritis, Janus kinase inhibitor, Placebo, and Methotrexate.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
Tofacitinib in Combination With Conventional Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient‐Reported Outcomes From a Phase III Randomized Controlled Trial
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis